Designing AI tools for Pathology: A mixed-method study on user interface design for breast cancer lymph node metastases detection

Intelligence-based medicine Pub Date : 2026-06-01 Epub Date: 2026-05-25 DOI:10.1016/j.ibmed.2026.100396
Sofia Jarkman , Martin Lindvall , Claes Lundström , Darren Treanor , Jeroen van der Laak
{"title":"Designing AI tools for Pathology: A mixed-method study on user interface design for breast cancer lymph node metastases detection","authors":"Sofia Jarkman ,&nbsp;Martin Lindvall ,&nbsp;Claes Lundström ,&nbsp;Darren Treanor ,&nbsp;Jeroen van der Laak","doi":"10.1016/j.ibmed.2026.100396","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Histopathological assessment of lymph nodes is essential in breast cancer care. Artificial intelligence (AI) has shown promise in supporting this process, yet successful clinical adoption requires attention to human-AI interaction and user interface design. This study explored the user experience of an AI-based clinical decision support tool assisting pathologists in diagnosing breast cancer metastases.</div></div><div><h3>Methods</h3><div>We conducted a within-subjects mixed-methods study in which ten pathologists evaluated two AI-based clinical decision support user interface prototypes for breast cancer metastasis detection in sentinel nodes. <em>ANNO</em> displayed threshold based on-image annotations with minimal automation, whereas <em>RAVS</em> presented four likelihood regions of interest (ROI) per slide with automated measurement and case summaries. Quantitative measures included review time, diagnostic outcomes, and System Usability Scale (SUS) scores. Qualitative data were gathered via semi-structured interviews and analysed thematically.</div></div><div><h3>Results</h3><div>ANNO achieved higher usability scores (mean SUS 90.3) and was associated with a sense of control and resembled current diagnostic workflow, whereas RAVS (mean SUS 80.0) was preferred by participants valuing rapid navigation and automated measurements. Interview findings highlighted trade-offs: ANNO preserved diagnostic overview and autonomy, while RAVS improved navigational efficiency but reduced whole-slide context. ROI presentation strategy seemed to influence preference. Trust in AI was generally cautious and linked to needs for transparency and long-term clinical exposure.</div></div><div><h3>Conclusion</h3><div>Both interfaces were perceived as potentially clinically valuable but differed in their usability and workflow integration. Our exploratory findings indicates that for future development of AI-based decision aiding tools for this diagnostic task, a combination of high human control with targeted automation is advisable, combined with visual clarity, and an effective ROI presentation strategy.</div></div>","PeriodicalId":73399,"journal":{"name":"Intelligence-based medicine","volume":"14 ","pages":"Article 100396"},"PeriodicalIF":0.0000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intelligence-based medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666521226000542","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Histopathological assessment of lymph nodes is essential in breast cancer care. Artificial intelligence (AI) has shown promise in supporting this process, yet successful clinical adoption requires attention to human-AI interaction and user interface design. This study explored the user experience of an AI-based clinical decision support tool assisting pathologists in diagnosing breast cancer metastases.

Methods

We conducted a within-subjects mixed-methods study in which ten pathologists evaluated two AI-based clinical decision support user interface prototypes for breast cancer metastasis detection in sentinel nodes. ANNO displayed threshold based on-image annotations with minimal automation, whereas RAVS presented four likelihood regions of interest (ROI) per slide with automated measurement and case summaries. Quantitative measures included review time, diagnostic outcomes, and System Usability Scale (SUS) scores. Qualitative data were gathered via semi-structured interviews and analysed thematically.

Results

ANNO achieved higher usability scores (mean SUS 90.3) and was associated with a sense of control and resembled current diagnostic workflow, whereas RAVS (mean SUS 80.0) was preferred by participants valuing rapid navigation and automated measurements. Interview findings highlighted trade-offs: ANNO preserved diagnostic overview and autonomy, while RAVS improved navigational efficiency but reduced whole-slide context. ROI presentation strategy seemed to influence preference. Trust in AI was generally cautious and linked to needs for transparency and long-term clinical exposure.

Conclusion

Both interfaces were perceived as potentially clinically valuable but differed in their usability and workflow integration. Our exploratory findings indicates that for future development of AI-based decision aiding tools for this diagnostic task, a combination of high human control with targeted automation is advisable, combined with visual clarity, and an effective ROI presentation strategy.
为病理学设计人工智能工具:乳腺癌淋巴结转移检测用户界面设计的混合方法研究
背景:淋巴结的组织病理学评估在乳腺癌治疗中是必不可少的。人工智能(AI)已经显示出支持这一过程的希望,但成功的临床应用需要关注人类与人工智能的交互和用户界面设计。本研究探讨了一种基于人工智能的临床决策支持工具的用户体验,帮助病理学家诊断乳腺癌转移。方法我们进行了一项受试者内混合方法研究,其中10名病理学家评估了两种基于人工智能的临床决策支持用户界面原型,用于乳腺癌前哨淋巴结转移检测。ANNO显示基于图像注释的阈值,自动化程度最低,而RAVS显示每个幻灯片的四个感兴趣的似然区域(ROI),具有自动化测量和案例摘要。定量测量包括审查时间、诊断结果和系统可用性量表(SUS)得分。通过半结构化访谈收集定性数据并进行主题分析。结果sanno获得了更高的可用性得分(平均SUS 90.3),并与控制感相关,类似于当前的诊断工作流程,而RAVS(平均SUS 80.0)更受重视快速导航和自动测量的参与者的青睐。访谈结果强调了权衡:ANNO保留了诊断概述和自主权,而RAVS提高了导航效率,但减少了整个幻灯片的背景。ROI呈现策略似乎影响偏好。对人工智能的信任总体上是谨慎的,并与透明度和长期临床暴露的需求有关。结论两种界面均被认为具有潜在的临床价值,但在可用性和工作流程集成方面存在差异。我们的探索性研究结果表明,对于未来基于人工智能的决策辅助工具的开发,建议将高度人工控制与目标自动化相结合,并结合视觉清晰度和有效的ROI呈现策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Intelligence-based medicine
Intelligence-based medicine Health Informatics
CiteScore
5.00
自引率
0.00%
发文量
0
审稿时长
187 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书